Buchhave 2008
Study characteristics | |||
Patient sampling | 148 MCI patients who performed the cube copying test were recruited from a memory clinic in a prospective manner. Sampling procedure is not fully described (mostly referred by general practitioners). Exclusion criteria involves: patients with other causes of cognitive impairment, including brain tumour, subdural haematoma, CNS infection, major depressive episode, schizophrenia and current alcohol abuse | ||
Patient characteristics and setting | This study included 148 MCI participants who performed the cube copying test and were diagnosed by the Petersen 1999 criteria at baseline. Physicians specialised in cognitive disorders performed a thorough physical, neurological and psychiatric examination, as well as a clinical interview, of each patient at baseline. Furthermore, analysis of apolipoprotein E (APOE) genotype and computed tomography of the brain were done Gender: 32 M, 30 F in MCI‐stable group; 20 M, 43 F in MCI‐AD group; 14 M, 8 F in MCI‐other dementias group Age: 66.2±8.8 years in MCI‐stable; 74.6±6.1 years in MCI‐AD; 72.7±9.0 years in MCI‐other dementia APOE ɛ 4 carrier: 32 in MCI‐stable; 20 in MCI‐AD; 14 in MCI‐other dementia MMSE at baseline: MCI‐stable 27.5±1.8; MCI‐AD 26.8±1.4; MCI‐other dementia 27.0 ± 1.7 Resources of referrals: "The majority of the subjects with MCI (74.1%) were referred by their general practitioners. The remaining MCI subjects were referred by other physicians (19.0%) or the patients themselves (6.8%)." Page 545 Resources of recruitment: memory disorder clinic, Malmo University Hospital, Sweden |
||
Index tests | Mini‐Mental state Examination (MMSE): no details about version, who administered and interpreted the test and scoring systems are provided. No threshold is pre‐specified. After analysis, authors estimated threshold in 28/29 score | ||
Target condition and reference standard(s) |
Main target condition for conversion: conversion from MCI to Alzheimer's disease dementia, vascular dementia, dementia by Lewy bodies or frontotemporal dementia Reference standard: for ADD = NINCDS‐ADRDA + DSM‐IIIR criteria; for VaD = DSM‐IIIR criteria + NINDS‐AIREN; for DLB = consensus criteria by McKeith 1999; for frontotemporal dementia = Brun 1994 |
||
Flow and timing |
Duration of follow‐up: average 5.2 years (range 4 to 6.8 years) At baseline :148 participants with MCI At follow up: 147 participants: 63 MCI‐AD; 22 MCI‐other dementia (15 VD; 4 LBD; 1 SD; 1 FTD; 1 dementia induced by traumatic brain injury); 62 stable‐MCI Conversion to AD N = 85; disease positive = 63; disease negative = 62 (p546); sensitivity = 89%; specificity = 33% (Table 2, p548) TP = 56; FP = 42; FN=7; TN=20 (Calculated in RevMan5) Loss to follow‐up: one participants died before 4 years follow‐up (≅ 1%) |
||
Comparative | |||
Notes | |||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Low | |||
DOMAIN 2: Index Test All tests | |||
Were sufficient data on MMSE application given for the test to be repeated in an independent study? | No | ||
Were MMSE results interpreted without knowledge of the reference standard? | Unclear | ||
Were MMSE thresholds prespecified? | No | ||
Low | |||
DOMAIN 3: Reference Standard | |||
Is the assessment used for clinical diagnosis of dementia acceptable? | Yes | ||
Was clinical assessment for dementia performed without knowledge of the MMSE results? | Unclear | ||
Unclear | |||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between MMSE and the reference standard? | Yes | ||
Did all participants receive the same reference standard? | Yes | ||
Were all participants included in the final analysis? | Yes | ||